Terlivaz

What is this medication? Terlivaz is an injectable prescription medicine containing the active ingredient terlipressin. It is primarily used to improve kidney function in adults suffering from hepatorenal syndrome with rapid reduction in kidney function. This condition is a life-threatening complication that often occurs in patients with advanced liver disease or cirrhosis, where the kidneys stop working correctly because of changes in blood circulation throughout the body.

The medication functions as a vasopressin analogue that helps to constrict blood vessels in the abdominal area. By narrowing these specific vessels, the drug helps to increase blood pressure and improve blood flow back to the kidneys. Terlivaz is administered by healthcare professionals in a hospital setting through an intravenous injection, usually as part of a comprehensive treatment plan to manage the severe effects of liver-related kidney failure.